Theophylline and silymarin are potent inhibitors of IL-4 secretion from activated human basophils

Hamidreza Jahanbani-Ardakani, Ghazale Bordbari, Nahid Eskandari, Ali Mohammad Sabzghabaee, Alireza Andalib

Abstract


Basophils are the most important cells in allergic reactions and secret interleukin 4 (IL-4) and tumor necrosis factor α (TNFα) mediators. Theophylline as a phosphodiesterase 4 inhibitor and silymarin with its anti-inflammatory effects seem to be useful drugs in treatment of allergic reactions. The aim of the present study was comparing effects of theophylline and silymarin on IL-4 and TNFα secretion by human basophils. After isolation of peripheral blood mononuclear cells, three cultures were designed; theophylline, silymarin and control cultures. Cultures were incubated for 15 minutes with theophylline, silymarin and buffer before challenging with bacteriallipopolysaccharide and anti-IgE antibody. IL-4 and TNFα mediators were assessed by ELISA assay and values of each culture were compared with control group. Silymarin and theophylline as potent inhibitors decreased secretion of IL-4 from human basophils significantly (P<0.01 and P<0.01, respectively). However, neither theophylline nor silymarin had significant effect on TNFα secretion (P=0.14 and P=0.08, respectively). These data suggest that silymarin and theophylline could regulate the generation of IL-4 from human basophils.


Keywords


Theophylline, silymarin, interleukin-4, tumor necrosis factor α, basophil

Full Text:

PDF

References


Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol 132:789-801, 2013.

Sokol CL, Medzhitov R. Role of basophils in the initiation of Th2 responses. Cur Opin Immunol 22:73-77, 2010.

Sokol CL, Chu N-Q, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nature Immunol 10:713-720, 2009.

Schneider E, Thieblemont N, De Moraes ML, Dy M. Basophils: new players in the cytokine network. Eur Cytokine Network 21:142-153, 2010.

Steiner M, Huber S, Harrer A, Himly M. The evolution of human basophil biology from neglect towards understanding of their immune functions. BioMed Res Int 8232830, 2016.

Gibbs BF. Basophils as key regulators of allergic inflammation and Th2-type immunity. World Allerg Org J 1:123-128, 2008.

Bannwart CF, Peracoli JC, Nakaira-Takahagi E, Peracoli MT. Inhibitory effect of silibinin on tumour necrosis factor-alpha and hydrogen peroxide production by human monocytes. Natural Prod Res 24:1747-1757, 2010.

Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol 39:172-179, 2007.

Kawakami A, Suzukawa M, Koketsu R, Komiya A, Ohta K, Yamamoto K, et al., editors. Enhancement of basophil apoptosis by olopatadine and theophylline. Allergy and Asthma Proceedings. OceanSide Publications, Inc., 2008.

Choi YH, Yan GH. Silibinin attenuates mast cell-mediated anaphylaxis-like reactions. Biolog Pharmaceut Bulletin 32:868-875, 2009.

Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M. Cyclic AMP: master regulator of innate immune cell function. Am J Resp Cell Mol Biol 39:127-132, 2008.

Page CP, Spina D. Selective PDE inhibitors as novel treatments for respiratory diseases. Cur Opin Pharmacol 12:275-286, 2012.

Margay SM, Farhat S, Kaur S, Teli HA. To study the efficacy and safety of doxophylline and theophylline in bronchial asthma. J Clin Diag Res 9:Fc05-08, 2015.

Iiboshi H, Ashitani J, Katoh S, Sano A, Matsumoto N, Mukae H, et al. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 20:46-51, 2007.

Kosmas E, Michaelides S, Polychronaki A, Roussou T, Toukmatzi S, Polychronopoulos V, et al. Theophylline induces a reduction in circulating interleukin‐4 and interleukin‐5 in atopic asthmatics. Eur Resp J 13:53-58, 1999.

Kang JS, Yoon WK, Han MH, Lee H, Lee CW, Lee KH, et al. Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice. Int Immunopharmacol 8:1475-1480, 2008.

Bakhshaee M, Jabbari F, Hoseini S, Farid R,

Sadeghian MH, Rajati M, et al. Effect of silymarin in the treatment of allergic rhinitis. Otolaryng Head Neck Surg 145:904-909, 2011.

Nakano J, Yano T, Yamamura K, Yoshihara H, Ohbayashi O, Yamashita N, et al. Aminophilline suppress the release of chemical mediators in treatment of acute asthma. Respir Med 100:542-550, 2006.

Chen ZC, Ding JJ, Qian HY, Lin XH, Feng KQ, Wang J. Clinical efficacies of inhaled corticosteroids plus theophylline in the treatment of bronchial asthma]. Zhonghua Yi Xue Za Zhi 93:1076-1079, 2013.

Eskandari N, Wickramasinghe T, Peachell PT. Effects of phosphodiesterase inhibitors on interleukin‐4 and interleukin‐13 generation from human basophils. Brit J Pharmacol 142:1265-1272, 2004.

Iiboshi H, Ashitani J-i, Katoh S, Sano A, Matsumoto N, Mukae H, et al. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-α in the sputum of patients with chronic obstructive pulmonary disease. Pulm Pharm Therap 20:46-51, 2007.

Min K, Yoon W-K, Kim SK, Kim B-H. Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis. Arch Pharm Res 30:1265-1272, 2007.

Kang JS, Park S-K, Yang K-H, Kim HM. Silymarin inhibits TNF‐α‐induced expression of adhesion molecules in human umbilical vein endothelial cells. FEBS Letters 550:89-93, 2003.

Alidoost F, Gharagozloo M, Bagherpour B, Jafarian A, Sajjadi SE, Hourfar H, et al. Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from beta-thalassemia major patients. Int Immunopharmacol 6:1305-1310, 2006.

Han MH, Yoon WK, Lee H, Han S-B, Lee K, Park S-K, et al. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice. Int Immunopharmacol 7:1651-1658, 2007.

Gharagozloo M, Karimi M, Amirghofran Z. Immunomodulatory effects of silymarin in patients with β-thalassemia major. Int Immunopharmacol 16:243-247, 2013.

Nazemian F, Karimi G, Moatamedi M, Charkazi S, Shamsara J, Mohammadpour AH. Effect of silymarin administration on TNF‐α serum concentration in peritoneal dialysis patients. Phytother Res 24:1654-1657, 2010.

Esmaeil N, Anaraki SB, Gharagozloo M, Moayedi B. Silymarin impacts on immune system as an immunomodulator: One key for many locks. Int Immunopharmacol 50:194-201, 2017.

Wei Q, Xu X, Ling Q, Zhou B, Zheng S-S. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma. Hepatobil Pancreat Dis Int 12:251-255, 2013.

Kim B-R, Seo H-S, Ku J-M, Kim G-J, Jeon CY, Park JH, et al. Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells. Inflamm Res 62:941-950, 2013.

Striz I, Brabcova E, Kolesar L, Liu X, Barcova I, Sekerkova A, et al. Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages. Immunobiology 216:1110-1116, 2011.


Refbacks

  • There are currently no refbacks.